Drug Type AAV based gene therapy |
Synonyms NGGT-003, NGGT003 |
Target |
Mechanism F8 stimulants(Coagulation factor VIII stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia A | Phase 1 | CN | 31 Jan 2024 |
Not Applicable | Hemophilia A FVIII | - | uqdonvfcah(exayefaxud) = shorter bleeding time pkultrdkny (valzqorapx ) View more | Positive | 07 May 2024 |